If discovery commences would not DNDN have the right to know the true share count during the class action period? If so then the SEC would/must open up and supply all shares both naked & legal for that would be the only TRUE way to find out who was actually damaged by DNDN's actions?
For if there are more shares floating around who then would be responsible for those holding shares that were NOT authorized? The SEC? I see this as a can of worms that will be stopped in its tracks. Sorry but the real cover up on why Provenge will be protected. And its not the 483 issue.
I am always for the truth and sincere sharing of information. So any factual information that you can share about the lawsuit would be appreciated. If not, then perhaps we should just all wait to see how the lawsuit comes about. Otherwise, the continuing hints at something sinister with never anything concrete weaved into feeble theories about how the FDA operate in illogical and inhumane way do have a feel of sneakiness. Hopefully that isn't your intent but that is how that came across.